Financial Ratios

DOCTORS BIOTECH INDIA LTD.

NSE : NABSE : 512079ISIN CODE : INE739D01027Industry : ChemicalsHouse : Private
BSE3.960 (0 %)
PREV CLOSE ( ) 3.96
OPEN PRICE ( ) 4.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )3.53 4.24
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsJun2004Jun2003Mar2002
Operational & Financial Ratios
   Earnings Per Share (Rs)0.211.011.28
   CEPS(Rs)0.030.120.08
   DPS(Rs)0.000.000.55
   Book NAV/Share(Rs)12.8212.6122.83
   Tax Rate(%)36.6213.365.14
Margin Ratios
   Core EBITDA Margin(%)10.349.887.22
   EBIT Margin(%)7.438.336.15
   Pre Tax Margin(%)7.408.316.07
   PAT Margin (%)4.697.205.75
   Cash Profit Margin (%)7.608.766.82
Performance Ratios
   ROA(%)1.447.515.15
   ROE(%)1.668.425.61
   ROCE(%)2.429.306.00
   Asset Turnover(x)0.311.040.89
   Sales/Fixed Asset(x)11.7525.6120.31
   Working Capital/Sales(x)0.331.051.02
Efficiency Ratios
   Fixed Capital/Sales(x)0.090.040.05
   Receivable days209.9548.3936.24
   Inventory Days0.000.000.00
   Payable days69.3818.3320.52
Valuation Parameters
   PER(x)140.0210.974.88
   PCE(x)863.8990.2382.26
   Price/Book(x)23.078.805.47
   Yield(%)0.000.000.44
   EV/Net Sales(x)65.917.985.57
   EV/Core EBITDA(x)637.2480.7477.19
   EV/EBIT(x)886.9695.8390.58
   EV/CE(x)19.967.734.98
   M Cap / Sales65.677.905.61
Growth Ratio
   Net Sales Growth(%)-67.9326.070.00
   Core EBITDA Growth(%)-66.4372.630.00
   EBIT Growth(%)-71.3770.660.00
   PAT Growth(%)-79.1157.820.00
   EPS Growth(%)-79.11-21.090.00
Financial Stability Ratios
   Total Debt/Equity(x)0.090.090.00
   Current Ratio(x)14.1216.2211.61
   Quick Ratio(x)14.1216.2211.61
   Interest Cover(x)243.65684.8272.56
   Total Debt/Mcap(x)0.010.020.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.